Fund moves

ResMed| (RMD): Jupiter Asset Management Ltd exited its position 143K shares

Jupiter Asset Management Ltd exited its position in ResMed|, per its Q2 2025 13F.

143K
Prior-quarter shares · no longer reported
Holdings as of
Jun 30, 2025
Filed
Aug 8, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 4, 2025Congress · 1 personMembers of Congress: 4 sales
  2. Jun 9, 2025InsiderCEO sold ~$2.01M of RMD shares in the open market
  3. Jul 1, 2025Insider · 2 peopleInsiders: 2 sales (~$1.0M)
  4. Jul 2, 2025InsiderDirector sold ~$241K of RMD shares in the open market
  5. Jul 7, 2025InsiderCEO sold ~$2.06M of RMD shares in the open market
  6. Aug 1, 2025Insider · 2 peopleInsiders: 2 sales (~$860K)
  7. Aug 7, 2025InsiderCEO sold ~$2.24M of RMD shares in the open market

What came next

  1. Aug 18, 2025InsiderDirector sold ~$739K of RMD shares in the open market
  2. Sep 2, 2025InsiderCFO sold ~$812K of RMD shares in the open market
  3. Sep 8, 2025InsiderCEO sold ~$2.23M of RMD shares in the open market
  4. Oct 1, 2025Insider · 2 peopleInsiders: 2 sales (~$851K)
  5. Oct 7, 2025InsiderCEO sold ~$2.27M of RMD shares in the open market
  6. Oct 30, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  7. Oct 30, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 13.7%
  8. Nov 3, 2025InsiderCFO sold ~$743K of RMD shares in the open market
  9. Nov 7, 2025InsiderCEO sold ~$2M of RMD shares in the open market
  10. Nov 11, 2025InsiderDirector sold ~$122K of RMD shares in the open market
  11. Nov 12, 2025InsiderDirector sold ~$504K of RMD shares in the open market
  12. Nov 19, 2025Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On November 19, 2025, our board of directors approved reducing the number of directors serving on our board from twelve (12) to eleven (11).”
  13. Nov 25, 2025InsiderDirector sold ~$524K of RMD shares in the open market
  14. Dec 1, 2025Insider · 2 peopleInsiders: 2 sales (~$256K)
  15. Dec 3, 2025InsiderDirector sold ~$503K of RMD shares in the open market
  16. Dec 5, 2025FDAFDA device clearance: Personalized Therapy Comfort Settings (PTCS)
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for ResMed|

For ResMed|, OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RMD page.

How this filing works

Explore the data

Common questions

What does this filing report about ResMed| (RMD) stock?

Jupiter Asset Management Ltd exited its position in ResMed|, per its Q2 2025 13F. Held the prior quarter, no longer listed per its Q2 2025 13F.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2025. Filed: Aug 8, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about ResMed| recently?

For ResMed|, OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the RMD page.

Does this mean RMD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at ResMed|

Everything OQRO holds on this company is on its RMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data